September 17, 2015 : Latest GLP-1 Receptor Agonists News

GLP-1 analog therapy hit a new threshold last month with the most prescriptions ever filled in a 30-day period. There are also more prescribers using these products than ever before. I think that one of the reasons is the fear of needles has decreased. I believe that it was not really a fear of needles for a lot of patients, but a fear of insulin and all the stigmas that went with it.

We can see the difference in the ease with which patients will use a GLP-1 analog, but would never consider insulin. To understand what I am talking about, just take a look a this month’s Case Study and how someone who wanted off insulin when they left the hospital had no problem using a GLP-1 analog.
Your partner in diabetes care,

Dave Joffe
Editor-in-chief

A 59 YOF is recently discharged from hospital after an allergic reaction to an anesthesia induction agent. She was placed on high-dose steroid for the reaction while she was in the hospital. Patient had completed her steroid tapering dose 2 months prior to her visit to endocrinology clinic today due to high blood glucose (a1c 8.9%). Past medical history included: hypertension, hyperlipidemia, atrial fibrillation, obesity and diabetes for 7 years. She was well controlled on metformin 1000mg BID before…

Dipeptidyl peptidase-4 (DPP4) inhibitors are generally well-tolerated for use in patients with severe renal impairment…

A recent study lists liraglutide as potentially having an early, unanticipated effect on glucagon in type 2 diabetes patients… In a recent randomized controlled trial, authors evaluated the use of liraglutide in 51 patients with type 2 diabetes for an average of 2.6 years. Patients were given either liraglutide or placebo for 48 weeks with …